AMSilk, an industrial supplier of synthetic silk biopolymers, together with the Fraunhofer Institute for Applied Polymer Research is developing innovative biofibres made from a silk protein of the green lacewing.

Researchers are working on producing the protein in large quantities by using biotechnology. The aim is to use the material in the future as a high-grade rigid fibre, for example, in lightweight composites in transportation technology.

It can also be conceivably used in medical technology, for example, as a biocompatible silk coating on implants, the company reports. The Fraunhofer IAP is presenting its initial material sample at the International Green Week Berlin, which runs from 20-29 January 2017.

Extremely rigid and stable

In order to protect their offspring from being eaten by predators near the ground, green lacewings deposit their eggs on the underside of leaves – on the ends of stable silk threads.  These so-called egg stalks are only around 15 micrometres thick and can easily hold the weight of the eggs.

In order to produce these impressive fibres, the green lacewing excretes a protein secretion onto the leaf. The egg is then laid in the droplet and perpendicularly pulled out from the leaf. The resulting silk thread then hardens in the air. 

“Unlike most other types of silk, the green lacewing’s egg stalk has a special structure with fascinating mechanical properties: green lacewing silk is extremely rigid and stable. We would like to transfer these special properties to fibres made from this silk. However, until now it has not been possible to produce this type of silk protein in sufficient quantities and purities,” commented Martin Schmidt, biotechnologist at the Fraunhofer IAP in Potsdam-Golm.

Biotech process

In a joint project with the company AMSilk, the researcher is working on manufacturing large amounts of green lacewing silk protein with the aid of bacteria using a biotech process. A team led by Professor Thomas Scheibel from the Chair of Biomaterials at the University of Bayreuth conducted the preliminary molecular-biological work. They constructed a special gene sequence which enables bacteria to produce the silk protein. 

Martin Schmidt is now optimising the manufacturing process at the Fraunhofer IAP so that the silk protein can be produced inexpensively on an industrial scale. Following this step, it will be possible to develop the material, believes Martin Schmidt.

Project support

AMSilk supports the project by conducting molecular biological work and by contributing its wide-ranging expertise in the field of silk analysis and production. The medium-sized company from Martinsried has been successfully developing silk-based biopolymers for various applications for years.

“We have been able to establish our silk technology and our first products are already available on the market. While the Biosteel fibre we use is modelled after spider silk and is more soft and flexible, green lacewing silk is very rigid. This special property makes it interesting for medical technology and as a reinforcement fibre in lightweight engineering, for example in cars, airplanes or ships. We are pleased to be working in partnership with the Fraunhofer IAP, which is able to lend its expertise to this project in every area – from the development of the silk material to the finished fibre,” commented Dr Lin Römer, scientific director of AMSilk.

www.iap.fraunhofer.de/en.html

www.amsilk.com